Ϫ
indicates that Slc26a6 functions as both a Cl Ϫ /HCO 3 Ϫ and a Cl Ϫ /OH Ϫ exchanger; simultaneous membrane hyperpolarization during these experimental maneuvers reveals that HCO 3 Ϫ and OH Ϫ transport mediated by Slc26a6 is electrogenic. Cis-inhibition and efflux experiments indicate that Slc26a6 can mediate the exchange of both Cl Ϫ and SO 4 2Ϫ with a number of substrates, including formate and oxalate. In contrast, SO 4 2Ϫ and oxalate transport by Slc26a1 are mutually cis-inhibited but activated significantly by extracellular halides, lactate, and formate. The data indicate that Slc26a6 encodes an apical Cl Ϫ /formate/oxalate and Cl Ϫ /base exchanger and reveal significant mechanistic differences between apical and basolateral oxalate exchangers of the proximal tubule.
oxalate; proximal tubule; formate; anion exchange; chloride ANION EXCHANGE AT THE PLASMA membrane is primarily mediated by the products of two structurally distinct gene families; the anion exchanger (AE) genes, which form a subset of the bicarbonate transporter, SLC4 superfamily (41, 52) , and the SLC26 or "sulfate permease" gene family (10, 33) . The mammalian SLC26 gene family has emerged over the last seven years through a combination of expression cloning (4), subtractive cDNA cloning (61) , and positional characterization of human disease genes (10) . Evolving physiological roles for specific family members include transepithelial salt transport (10, 45) , thyroidal iodide transport (46) , development and function of the inner ear (10, 61) , sulfation of extracellular matrix (43) , and the renal excretion of both bicarbonate (42) and oxalate (17) . The various substrates transported by the SLC26 anion exchangers include sulfate (SO 4 2Ϫ ), chloride (Cl 
, formate, oxalate, hydroxyl ion (OH Ϫ ), and bicarbonate (HCO 3 Ϫ ) (4, 17, 36, 43, 45, 49) . The SLC26 gene family is highly conserved across evolution, with identifiable homologues in bacteria, fungi, yeast, plants, and animals (10) . The Drosophila genome contains at least nine family members, and the existence of new mammalian paralogs has been suspected for some time (10) . The cloning of several of these new genes has been recently reported (19, 30, 31, 53, 54) , and the family appears to encompass 10 members and 1 pseudogene (Mount DB, unpublished observations). Physiological interest in the characterization of novel family members was stimulated in particular by the observation that SLC26A4 can function as a Cl Ϫ /formate exchanger (45) , because Cl Ϫ /formate exchange is thought to play a pivotal role in the transepithelial transport of NaCl by the renal proximal tubule (56, 57) . However, Slc26a4 is not expressed in the proximal tubule but is instead found at the apical membrane of ␤-intercalated cells, where it appears to play a role in renal bicarbonate excretion (42) . The sixth member of the gene family, SLC26A6, was recently cloned in both humans (SLC26A6) (30, 54) and mice (Slc26a6, also known as CFEX) (19) . Functional characterization of Slc26a6 indicates that it can mediate both Cl Ϫ /formate and Cl Ϫ /Cl Ϫ exchange (19) , whereas the human ortholog was nonfunctional (54) .
The immunolocalization of SLC26A6 and Slc26a6 indicates expression at the apical membrane of epithelial cells (19, 30) . Apical oxalate transport by a DIDS-sensitive anion exchanger is thus thought to play an important role in oxalate secretion by the proximal tubule, in concert with basolateral oxalate transport mediated by Sat-1 (SLC26A1/ Slc26a1). There is also a significant body of evidence suggesting that apical Cl Ϫ /base exchange functions in transepithelial NaCl absorption by the proximal tubule (24) . Moreover, the ability of SLC26 proteins to function as Cl Ϫ /base exchangers identifies Slc26a6 as a candidate for both the apical Cl Ϫ /base exchanger of the proximal tubule and the apical CFTR-dependent bicarbonate transporter(s) in the lung (26) , submandibular gland (27) , and exocrine pancreas (7, 27) . We report the initial exploration of these issues, in addition to a functional comparison of the murine Slc26a1 and Slc26a6 anion exchangers.
METHODS

Molecular characterization of Slc26a6 and Slc26a1
. Human SLC26A6 exons were initially identified in the draft sequences of the BAC clone RP11-148G20 and the PAC clone RP4-751E10, using tblastn searches of the HTGS database with the SLC26A1-4 proteins. A blastn search of the mouse expressed sequence tag (EST) database using the extracted human exon contig yielded a Sugano mouse IMAGE clone (2076921), with 5Ј-and 3Ј-EST entries that exhibited modest homology to the NH 2 and COOH termini of known SLC26 proteins. This full-length cDNA was obtained from Research Genetics (Birmingham, AL), sequenced on both strands using fluorescent dye terminator chemistry (Applied Biosystems), and submitted to GenBank (AF248494, 3/23/00). A blastn search of the Celera mouse genomic database yielded a 500-kb contig containing the 11-kb Slc26a6 gene, and a subsequent blastn search of the mouse EST database using a 1.7-kb region between the start of the 2076921 EST and the 3Ј-untranslated region (UTR) of the upstream gene yielded three RIKEN 5Ј-ESTs that overlap with 2076921 but have a different 5Ј-end. This alternative 5Ј-end was cloned by RT-PCR from mouse intestine total RNA, using a sense primer in exon 1a (5Ј-TACACGAGTTACCCTCTGAGG-3Ј) and an antisense primer from within exon 4 (5Ј-TACAGACCAAACAT-AGGAGGC-3Ј), as described (37) . The two amplified PCR fragments obtained (see Fig. 2 ) were subcloned into pCR2.1 (Invitrogen) and sequenced. Finally, for the purpose of functional comparison to Slc26a6, we identified and sequenced a full-length mouse Slc26a1 EST (IMAGE clone 1450460).
The analysis of nucleotide and amino acid sequence utilized Vector NTI 6.0 (Informax), supplemented by GRAIL (http:// compbio.ornl.gov/Grail-1.3/), Phosphobase (http://www.cbs. dtu.dk/databases/PhosphoBase/), MattInspector (http://transfac. gbf.de/cgi-bin/matSearch/matsearch.pl), TESS (http://www. cbil.upenn.edu/cgi-bin/tess/tess33?RQϭSEA-FR-Query), and Prosite (http://www.expasy.ch/prosite/). Genomic localization of Slc26a1 and Slc26a6 exploited Celera genomic contigs encompassing the two genes, the UniSTS website (NCBI), and the Mouse Genome Database (MGD; http://www. informatics.jax.org/mgihome/).
Northern blot analysis. RNA was extracted from C57BL/6J mice using guanidine isothiocyanate and cesium chloride. Total RNA (10 g/lane) was size-fractionated by electrophoresis (5% formaldehyde, 1% agarose), transferred to a nylon membrane (Stratagene), and probed sequentially with 32 P-labeled randomly primed probes corresponding to fulllength GAPDH and a 3Ј-probe from Slc26a6 (nucleotides 2339-2673 of Slc26a6b). Hybridization was performed overnight at 42°C in Express-Hyb solution (Clontech), and membranes were washed twice for 10 min at room temperature in 2ϫ SSCP/0.1% SDS and twice for 1 h at 65°C in 0.1ϫ SSCP/0.1% SDS.
Expression of Slc26a1 and Slc26a6 in Xenopus laevis oocytes. The entire inserts of the Slc26a6b and Slc26a1 cDNAs were transferred to the pGEMHE X. laevis expression vector (29) using EcoRI and XbaI. The Slc26a6b and Slc26a1 expression constructs were linearized using NheI and NotI, respectively, and cRNA was transcribed in vitro using T7 RNA polymerase and mMESSAGE mMACHINE kits (Ambion). Defolliculated oocytes were injected with 25-50 nl of water or a solution containing cRNA at a concentration of 0.5 g/l (12.5-25 ng/oocyte), using a Nanoliter-2000 injector (WPI Instruments, Sarasota, FL). Oocytes were incubated at 17°C in 50% Leibovitz's L-15 media supplemented with PenStrep (1,000 U/ml) and glutamine for 2-3 days before uptake assays.
For sulfate uptakes, oocytes were preincubated for 20 min in chloride-free uptake medium [100 mM N-methyl-D-glucamine (NMDG)-gluconate, 2 mM potassium gluconate, 1 mM calcium gluconate, 1 mM magnesium gluconate, 10 mM HEPES-Tris, pH 6.0 or pH 7.5, as indicated], followed by a 60-min uptake in the same medium with 1 mM K 2 35 SO4. The cells were then washed three times in uptake buffer with 5 mM nonradioactive K 2SO4 to remove tracer activity in the extracellular fluid. The oocytes were dissolved individually in 10% SDS, and tracer activity was determined by scintillation counting. Cl Ϫ , formate, and oxalate uptakes were assayed using the same Cl Ϫ -free uptake solutions, substituting 8. Fig. 5C ) and cisinhibition (Fig. 5A) , the concentration of NMDG-gluconate in the uptake solution was adjusted to maintain isotonic osmolality, which was experimentally confirmed using a Fiske 110 osmometer. Cis-inhibition experiments used the Na ϩ salts of the relevant anions. All radioisotopes were from New England Nuclear (Boston, MA).
The uptake experiments all included 12-18 oocytes in each experimental group, statistical significance was defined as twotailed (P Ͻ 0.05), and results are reported as means Ϯ SE.
Oocyte electrophysiology. Oocytes were studied 3-11 days postinjection. The CO 2 . All solutions were titrated to pH 7.5 and continuously bubbled with CO2-balanced O2 to maintain PCO2 and pH. Ion-selective microelectrodes were prepared and calibrated, and experiments were performed as previously described for NBC (40) and NDAE1 (41) . All pH electrodes had slopes of at least Ϫ56 mV/decade concentration change. Where statistical tests were indicated, a two-tailed Student's t-test assuming unequal variances was used. P values Ͻ0.05 were considered statistically significant.
RESULTS
Molecular biology.
Sequence comparison indicates that the murine Slc26a6 and human SLC26A6 orthologs share only 78% identity at the amino acid level, much lower than the median of 86% for human and mouse orthologous pairs (32) . However, the murine and human genes are clearly orthologous, such that both are flanked at the 5Ј-ends by the FMI-1/MEGF-2 gene and at the 3Ј-end by the UQCRC1 and ColA7 genes (13, 28) . The gene and sequence tagged site content of these contigs confirm that the human SLC26A6 gene is on chromosome 3p21 (30) and the murine gene is in the syntenic segment of chromosome 9, at ϳ61 cM. In particular, the murine ColA7 gene is physically linked ϳ40 kb 3Ј of Slc26a6 and is known to be localized on mouse chromosome 9 at 61.0 cM (Uni-STS marker 859381) (28) .
The Slc26a6 and SLC26A6 genes share a similar organization, encompassing 21 coding exons and ϳ10 kb of genomic DNA. Both genes include an alternative 5Ј noncoding exon (exon 1b, 945 nucleotides 5Ј of coding exon 2 in Slc26a6). Nonquantitative RT-PCR using primers in exons 1a and 4 (see Fig. 2A ) suggests that the isoform in which exon 1b has been spliced out, denoted Slc26a6a, is expressed at a lower level than Slc26a6b; our functional experiments utilized a Slc26a6b construct. The identity of the two RT-PCR fragments (see Fig. 2A ) was verified by subcloning and sequencing of the amplified bands. The intron-exon boundaries in Slc26a6 were determined by comparison of the various Slc26a6 cDNAs to the murine Celera contig, and all of the donor and acceptor sites were found to conform to consensus splice sites (39) ( Table  1 ). The inclusion of exon 1b in the longer Slc26a6b transcript results in a frame shift and a start codon within exon 2. The predicted Slc26a6b protein is thus 23 amino acids shorter than Slc26a6a (Fig. 1) . The start codons in exon 1a and exon 2 are both predicted Kozak sites (21) , with purines at position Ϫ3 and G at position ϩ4. However, it is conceivable that the Kozak site in exon 2 is in fact preferred for translation initiation in both the Slc26a6a and Slc26a6b transcripts; formal proof that the start codon in exon 1a is utilized will require the generation of an antibody to the putative NH 2 -terminal extension of the Slc26a6a protein.
Slc26a6b is essentially identical to the sequence of mouse "CFEX" (19) , except for codons 2 (glutamate in Slc26a6b, glycine in CFEX), 65 (valine in Slc26a6b, indeterminate in CFEX), and 549 (proline in Slc26a6b, arginine in CFEX). Exon 1b is conserved in the human genomic sequence; the cDNA reported by Waldegger et al. (54) corresponds to SLC26A6a, whereas that reported by Lohi et al. (30) corresponds to SLC26A6b. The functional significance of the alternative NH 2 terminus in the Slc26a6a isoform is not yet known; however, note is made of the conservation of the sequence, TQALLS, in mice, humans, and pigs ( Fig. 1 and data not shown, porcine SLC26A6a). The murine Slc26a6b isoform lacking the NH 2 -terminal extension is functional (see Figs. 4-7); hence, this sequence is not required for transport activity.
Northern blot analysis indicates that the Slc26a6 gene is widely expressed, with a 3.0-kb transcript detected in intestine, kidney, testis, brain, muscle, heart, and stomach (Fig. 2B) ; hybridization levels for GAPDH were approximately equal (not shown). The widespread expression of Slc26a6 is consistent with the presence of a CpG island overlapping exon 1a in the 
ACGCAGGCCACC GCCACC (3Ј-UTR)
Intron-exon boundaries, exon lengths, and encoded codons are shown for the 22 exons of mouse Slc26a6. Exon 1b is an alternatively spliced noncoding exon ( Fig. 2A) . Codons are numbered for the longer Slc26a6a protein, generated from transcripts lacking exon 1b. Superscripts indicate the position of the first and last nucleotide of each exon within the relevant codons; UTR, untranslated region.
Celera genomic contig ( Fig. 3) , conserved in the human gene (data not shown). Although the transcriptional start site has not been mapped for either species, the most 5Ј Slc26a6a ESTs begin ϳ100 bp 5Ј of the start codon in exon 1a. The genomic DNA flanking in exon 1a suggests a TATA-less promoter, rich in predicted Sp1 sites (Fig. 3) .
For the purpose of functional comparison to Slc26a6, we also characterized mouse Slc26a1 (Sat-1), identified on a full-length EST cDNA (Fig. 1B) . The predicted Slc26a1 protein is 91 and 76% identical to the rat and human SLC26A1 proteins, respectively. As is the case with Slc26a6/SLC26A6, the mouse and human Slc26a1/SLC26A1 genes are clearly orthologous. Large genomic contigs containing the mouse (Celera) and human (GenBank NT_006111) genes reveal a conserved organization, such that both are flanked at the 5Ј-end by the FGFRL-1 (59), GAK (18) , and DAGK4 (9) genes and at the 3Ј-end by the L-iduronidase gene. The murine FGFRL-1 and L-iduronidase genes have both been localized on mouse chromosome 5 at ϳ57 cM (59), syntenic with the region of human chromosome 4p16 containing SLC26A1, GAK (18) , and DAGK4 (9) . The genomic organization of the two SLC26A1/Slc26a1 genes is also conserved, although analysis of a number of 5Ј Slc26a1 ESTs reveals the existence of two 5Ј noncoding exons in the murine gene ( Table 2 ). The more 3Ј of these two noncoding exons, denoted exon 1b, RT-PCR of mouse tissues, using a sense primer in exon 1a and an antisense primer in exon 4. Reaction products were run on a 6% acrylamide gel; controls include both water and an RT-negative (Ϫ) sample. The Slc26a6a transcript yields a 300-bp band due to alternative splicing of the 5Ј exon 1b, whereas the Slc26a6b transcript yields a 438-bp band due to retention of this exon. B: mouse multiple-tissue Northern blot, probed with a 3Ј probe specific for Slc26a6 (4-day exposure).
is excluded from a number of ESTs, indicating that it is alternatively spliced. Of note, the relative position of the junction between the two coding exons of SLC26A1/ Slc26a1 and SLC26A2 (DTDST), which together form a separate branch of the gene family, is conserved in the respective mouse and human genes.
Anion transport in X. laevis oocytes. We have characterized the physiological properties of mouse Slc26a6b and Slc26a1 in X. laevis oocytes using similar protocols to those published for SLC26A1 (4, 25, 43) , SLC26A2 (43), SLC26A3 (36) , and SLC26A4 (45, 46) . Figure 4 illustrates the uptake of 35 SO 4 2Ϫ uptake between pH 7.4 and 6.0 is significant for Slc26a1 (P Ͻ 0.02) but not for Slc26a6. Both transporters are more sensitive to 1 mM DIDS at the lower pH (301 Ϯ 24 pmol ⅐ oocyte Ϫ1 ⅐ h Ϫ1 at pH 7.4 vs. 101 Ϯ 10 pmol ⅐ oocyte Ϫ1 ⅐ h Ϫ1 at pH 6.0 for Slc26a6 in the presence of DIDS). In contrast, Cl Ϫ uptake in Slc26a6/CFEX-expressing oocytes was reported by Knauf et al. (19) to be highly sensitive to 100 M DIDS, with no significant difference between pH 7.4 and 6.5; this higher sensitivity may have masked an effect of extracellular pH. It is also likely that DIDS sensitivities of Slc26a6 and other members of the family are highly dependent on both the concentration and the identity of the transported anion (16), although we note that SLC26A3 and SLC26A4 are also only modestly sensitive to DIDS (1, 46) .
Oocytes expressing Slc26a6 transported 36 Cl Ϫ (Fig.  4B) , although, again, there was no consistent difference between pH 7.4 and 6.0 for Slc26a6-injected groups (4,345 Ϯ 243 and 4,193 Ϯ 109 pmol ⅐ Fig. 3 . Sequence of the proximal promoter from the Slc26a6 gene. Genomic sequence surrounding exon 1a is displayed. This data was generated through the use of the Celera Discovery System and Celera's associated databases. Coding sequence from the 3Ј-end of exon 1a is underlined in bold, beginning with the predicted "ATG" start codon. The predicted CpG island is indicated by bold brackets. Potential binding sites for transcription factors, predicted using TESS and Mattinspector, are boxed and labeled. (Fig. 4B) .
The absolute rates of 35 SO 4 2Ϫ uptake for Slc26a1-injected oocytes shown in Fig. 4A are reproducibly lower than those of Slc26a6-injected oocytes. However, SO 4 2Ϫ uptake rates for Slc26a1 are much higher in the presence of extracellular Cl Ϫ , closer to the values for Slc26a6 in the absence of Cl Ϫ (Fig. 4C) . In contrast, 35 SO 4 2Ϫ uptake by Slc26a6-injected cells is strongly cis-inhibited by extracellular Cl Ϫ (Fig. 4C) , consistent with the ability of this exchanger to mediate 36 Cl Ϫ uptake (Fig. 4B) . The increase in 35 SO 4 2Ϫ transport by Slc26a1 at an extracellular pH of 6.0 is greater in the presence (Fig. 4D ) than in the absence (Fig. 4A ) of extracellular Cl Ϫ . A shared property of the SLC26 anion exchangers is cis-inhibition of the uptake of a given ion by other substrates (19, 36, 43, 45) . To assess the repertoire of substrates capable of cis-inhibiting Cl Ϫ uptake by Slc26a6, we incubated Slc26a6-injected oocytes with sulfate, formate, halides, nitrate, and lactate; all but lactate significantly inhibit 36 Cl Ϫ uptake (Fig. 5A) . A similar profile was obtained for SO 4 2Ϫ transport (Fig.  5B) . We also assessed the ability of Slc26a6 to mediate SO 4 2Ϫ exchange by measuring efflux of this tracer in the presence of extracellular substrates (45) . For this ex- periment, oocytes were incubated in 35 SO 4 2Ϫ uptake media for 1 h and then incubated in the absence (control group) or the presence of the substrates indicated in Fig. 5C Fig. 4A . As one would predict from the cis-inhibition experiments shown in Fig. 5 , Slc26a6-injected oocytes transport both oxalate (487 Ϯ 50 vs. 12 Ϯ 1 pmol⅐oocyte Ϫ1 ⅐h Ϫ1 in water-injected controls, Fig. 6A ) and formate (45 Ϯ 5 vs. 7 pmol⅐oocyte Ϫ1 ⅐h Ϫ1 in water-injected controls, Fig. 6B ). In contrast, Slc26a1 mediates the transport of oxalate (72 Ϯ 2 pmol⅐ oocyte Ϫ1 ⅐ h Ϫ1 , Fig. 6A ), as reported for rat Slc26a1 (17), but not formate (7 pmol ⅐ oocyte Ϫ1 ⅐ h Ϫ1 , Fig. 6B ).
The activation of (rat) Slc26a1 by extracellular Cl Ϫ (Fig. 4C ) has been observed before (43) but not explored in detail. To extend this observation, we first examined (Fig. 7A) . Although the ability of Slc26a1 to transport all of these monovalent ions has not been examined, it transports neither Cl Ϫ (Fig. 4B) nor formate (Fig. 6B) . Moreover, I Ϫ and Br Ϫ are both cis-inhibitory for both SO 4 2Ϫ and Cl Ϫ uptake via Slc26a6, indicating that they are potential substrates, as shown directly for SLC26A4 in the case of I Ϫ (46); by extension, these are not likely substrates for Slc26a1. The activation of Slc26a1 by impermeant anions is not unique to SO 4 2Ϫ transport, because oxalate transport in Slc26a1-injected oocytes is also higher in the presence of Cl Ϫ and other anions (Fig. 7B) . Slc26a6 serves as a control for the latter experiment, in that oxalate transport by oocytes injected with this cRNA is strongly cis-inhibited by these anions (Fig. 7B) .
Oocyte intracellular pH and electrophysiology. Figure 8 illustrates an experiment with single water-and Slc26a6-injected oocytes; however, these results were observed for Slc26a6-injected oocytes from five separate frogs; rates are reported for both the single oocytes shown in Fig. 8 and for the mean of several oocytes (in parentheses). Figure 8 shows that a water-injected oocyte exposed to 5% CO 2 (Fig. 6B) Ϫ causes a slight but abrupt depolarization in Slc26a6-injected oocytes (3.1 Ϯ 0.6 mV, n ϭ 9), reminiscent of the anion conductance observed in oocytes expressing NDAE1 (41) . Cl Ϫ replacement (gluconate) does not affect pH i of the water-injected control (ϩ6.0 Ϯ 2.2 ϫ 10 Ϫ5 pH units/s, n ϭ 8; Fig. 8A ). However, Fig. 8B illustrates that Cl Ϫ removal increases pH i of a Slc26a6 oocyte at the rate of 44 ϫ 10 Ϫ5 pH units/s (ϩ72 Ϯ 8.8 ϫ 10 Ϫ5 pH units/s, n ϭ 10; Fig. 8B ), which ceases after Cl Ϫ readdition. Surprisingly, this gluconate replacement evokes a 37-mV hyperpolarization (Ϫ22.7 Ϯ 2.9 mV, n ϭ 9; vs. ϩ0.2 Ϯ 2.0 mV, n ϭ 8 for controls). A second Cl Ϫ removal in Fig. 8B alkalinizes the cell at 28 ϫ 10 Ϫ5 pH units/s (ϩ41 Ϯ 6.2 ϫ 10 Ϫ5 pH units/s, n ϭ 8) and reproduces the hyperpolarization (Ϫ18.6 Ϯ 3.8 mV, n ϭ 8). In all the experiments with Slc26a6-injected oocytes, the second alkalinization induced by Cl Ϫ removal, which occurs at a higher pH i , has a lower rate (ϩ72 ϫ 10 Ϫ5 pH units/s for the first alkalinization and ϩ41 ϫ 10 Ϫ5 vs. ϩ6.0 ϫ 10 Ϫ5 pH units/s for the single Cl Ϫ removal in water-injected oocytes). We also replaced Na ϩ with choline to test cation dependence of Slc26a6. Na ϩ removal and replacement did not obviously affect pH i . Before CO 2 removal, pH i rose to 7.2, i.e., almost the non-HCO 3 Ϫ level. Finally, removal of 5% CO 2 /33 mM HCO 3 Ϫ elicits a robust alkalinization and pH i overshoot to 7.9 (7.83 Ϯ 0.07, n ϭ 10), indicative of cellular HCO 3 Ϫ loading [change in (⌬)pH i for Slc26a6 is ϩ0.53 Ϯ 0.07, n ϭ 10] (40, 41). This overshoot is not observed in controls (⌬pH i for controls is ϩ0.02 Ϯ 0.04, n ϭ 8) (40, 41) .
Because Slc26a6 clearly functions as a Cl Ϫ /HCO 3 Ϫ exchanger (Fig. 8B) , we tested whether it could function as a Cl
we continuously bubbled all the non-HCO 3 Ϫ solutions with 100% O 2 as previously described in the characterization of NDAE1 (41) . Figure 9 illustrates the non-HCO 3 Ϫ responses of one control and one Slc26a6 oocyte; the data for these two oocytes are detailed in the legend for Fig. 9 . Data for the mean of several oocytes and several frogs are written in parentheses. Bath Cl Ϫ transport mediated by Slc26a6, characterized using ion-selective microelectrodes. A: experiment monitoring intracellular pH (pHi) and membrane potential (Vm) of a water-injected oocyte. Addition of 5% CO2/33 mM HCO 3 Ϫ (pH 7.5) to the bath elicited a slight depolarization and results in cell acidification; CO2 diffuses across the membrane, forms H2CO3, and then subsequently generates H ϩ and HCO 3 Ϫ from fast dissociation. B: experiment monitoring pHi and Vm of a Slc26a6 oocyte. The initial pH and rate of CO2-induced acidification are equivalent to those of the water-injected control. In the continuing presence of 5% CO2 /33 mM HCO 3 Ϫ (pH 7.5), Cl Ϫ removal elicits a robust alkalinization that halts with Cl Ϫ readdition. Simultaneously, there is a pronounced and reversible hyperpolarization not observed in control oocytes. Replacement of Na ϩ (choline) elicits no change in (⌬)pHi and a small hyperpolarization as observed in control cells. A second Cl Ϫ removal elicits a lesser alkalinization and a second hyperpolarization. Ϫ5 pH units/s) and minimally changes Vm (0 Cl Ϫ ⌬Vm ϭ Ϫ9.9 mV). Similarly, readdition of Cl Ϫ elicits minimal pHi (⌬pHi ϭ 0.00) and Vm changes (plus Cl Ϫ ⌬Vm ϭ ϩ2.7 mV). B: experiment monitoring pHi and Vm of an Slc26a6-injected oocyte is shown. For this experiment, the initial baseline pH (7.23) is slightly elevated compared with the water-injected control (pHi ϭ 7.19, Fig 9A) . In the nominal absence of HCO 3 Ϫ (O2 bubbling), Cl Ϫ removal elicits an alkalinization (⌬pHi ϭ 0.07 pH units; rate ⌬pHi ϭ ϩ23.0 ϫ 10 Ϫ5 pH units/s) that halts with Cl Ϫ readdition. Simultaneously, there is a reversible hyperpolarization (0 Cl Ϫ ⌬Vm ϭ Ϫ13.0 mV) with a pronounced depolarization induced by the readdition of Cl Ϫ (plus Cl Ϫ ⌬Vm ϭ ϩ45.7 mV).
removal of control oocytes (Fig. 9A) does not change pH i (Ϫ2.1 Ϯ 1.8 ϫ 10 Ϫ5 pH units/s, n ϭ 7) or membrane potential (ϩ1.1 Ϯ 1.7 mV, n ϭ 14). Nevertheless, this same maneuver alkalinized (ϩ27 Ϯ 6.4 ϫ 10 Ϫ5 pH units/s, n ϭ 6) and hyperpolarized (Ϫ9.1 Ϯ 3.0 mV, n ϭ 11; P Ͻ 0.008) Slc26a6 oocytes (Fig. 9B) . Cl Ϫ readdition to the bath stopped the alkalinization and returned membrane potential to the initial value. However, the readdition of Cl Ϫ evoked a large transient depolarization (ϩ39.6 Ϯ 4.9 mV, n ϭ 11 for Slc26a6 vs. Ϫ4.6 Ϯ 0.9 mV, n ϭ 14 for controls; P Ͻ 0.000002) followed by a smaller sustained depolarization.
DISCUSSION
We report here the molecular and functional characterization of Slc26a1 and Slc26a6, the first and sixth members of the murine Slc26 gene family of anion exchangers. We have also reported on the chromosomal localization and genomic structure of the two genes, along with evidence of alternative splicing of both transcripts. Immunolocalization and functional characterization recently identified Slc26a6 as the putative Cl Ϫ / formate exchanger of the renal proximal tubular epithelium (19) The sequence comparison of mouse Slc26a6 reveals that the closest characterized relative is prestin (Slc26a5), with 39% identity at the amino acid level, whereas Slc26a1 is closest to Slc26a2 (DTDST, 47% identity). The COOH-terminal domains of both Slc26a1 and Slc26a6 contain predicted sulfate transporter and anti-sigma (STAS) domains, recently defined by virtue of homology between the SLC26 gene family and bacterial anti-sigma factor antagonists (2) . Structural predictions suggest a role for the STAS domain in nucleotide binding and/or hydrolysis (2) . With the exception of a COOH-terminal type I PDZ interaction motif (51) (see below), analysis of the Slc26a6 protein with motif-based algorithms (44, 60) does not reveal other protein-signaling domains or motifs. Mouse and rat Slc26a1 (4) predict a COOHterminal type I PDZ binding motif (S-A-L); however, this motif is not conserved in the human protein (GenBank AF297659). Analysis using both the Prosite and Phosphobase (22) databases reveals that Slc26a1 and Slc26a6 are both potential substrates for a number of protein kinases, including tyrosine kinases, protein kinase A, and protein kinase C (Fig. 1) .
We 
Cl
Ϫ uptake by Slc26a6 by a more acidic extracellular medium (Fig. 4B) is somewhat surprising, given that this protein can mediate Cl Ϫ /OH Ϫ exchange (Fig.  9) . However, similar findings for the pH dependency of Slc26a6 Cl Ϫ uptake were reported by Knauf et al. (19) . Slc26a6 shares the ability to mediate Cl Ϫ /base exchange with Slc26a3 (34) and Slc26a4 (42, 49) . However, the electrophysiology of this mode of anion transport has not been studied in the SLC26 anion exchangers. We have found that removal of extracellular Cl Ϫ in the presence of HCO 3 Ϫ evokes a significant hyperpolarization. The simplest explanation is that Slc26a6 mediates electrogenic HCO 3 Ϫ transport. That is, these data are consistent with 1) cation (e.g., H ϩ ) coexit with Cl Ϫ ; 2) the entry of another anion with HCO 3 Ϫ into the cell; or 3) exchange of more than one HCO 3 Ϫ ion for each Cl Ϫ ion that exits. We cannot rule out the possibility that Slc26a6 overexpression somehow evokes an otherwise silent conductance natively present in the oocyte, and future experiments will examine the nature of these Cl Ϫ -suppressed voltage or current changes. However, unmasking an otherwise silent conductance in response to Slc26a6 expression seems unlikely, because there is not a precedent in the literature for a "Cl Ϫ -inhibited anion current" as measured in our experiments.
Although complete functional characterization is lacking for many of the SLC26 anion exchangers, the range of substrates intrinsic to Slc26a6 is tentatively only matched by that of SLC26A3 (DRA) (5, 34, 36, 54) . Of note, however, formate transport has not been reported for SLC26A3, and only low-level oxalate, Cl Ϫ , and SO 4 2Ϫ uptake compared with water-injected controls has been reported for SLC26A3-injected oocytes (36, 48) . In contrast to Slc26a6, Slc26a1 does not transport Cl Ϫ or formate but does transport SO 4 2Ϫ and oxalate (Figs. 4-7) . SLC26A2, in turn, is known to transport monovalent anions such as Cl Ϫ , I Ϫ , and formate, but not divalent anions such as SO 4 2Ϫ and oxalate (45, 46) . This combination of functional divergence and structural homology within the SLC26 gene family will no doubt aid the structure-function analysis of anion specificity.
The data reported here reveal that transport of the divalent anions SO 4 2Ϫ and oxalate by Slc26a1 is strongly activated by impermeant, monovalent anions such as Cl Ϫ and formate. This is, presumably, not simply a matter of the valence of anionic charge, because HCO 3 Ϫ reportedly does not activate SO 4 2Ϫ uptake by rat Slc26a1 (43) . The physiological significance of this phenomenon is not yet clear; however, this functional characteristic of Slc26a1 is dramatically different from that of other SLC26 anion exchangers, including Slc26a2 (43) . It is hoped that a comparative structure-function analysis of Slc26a1 and Slc26a2 will yield some insight into the molecular mechanism. As shown in Fig. 4, SO 4 2Ϫ exchange by Slc26a1 is significantly stimulated by an acid-outside pH gradient, particularly in the presence of extracellular Cl Ϫ (Fig. 4C ). This is suggestive of H (Fig. 8) . The question of whether two separate gene products mediate Cl Ϫ /formate exchange in the proximal tubule awaits the characterization of Slc26a6 knockout mice, along with the full pharmacological characterization of the Slc26a6 in its various transport modes (16 (50) , consistent with the expression of Slc26a6 in heart and skeletal muscle (Fig. 2) . The role of Slc26a6 in Cl Ϫ /HCO 3 Ϫ exchange (Fig. 8) is of particular relevance to the physiology of tissues that excrete HCO 3 Ϫ under the influence of CFTR (7, 26, 27) . Suggestive evidence that CFTR might regulate SLC26A6 was initially reported in a study of cystic fibrosis pancreatic cell lines, in which the expression of wild-type CFTR results in a 10-fold activation of DIDS-sensitive sulfate transport (8) . More recently, Greeley et al. (12) reported that stable transfection of cystic fibrosis pancreatic cell lines with wildtype CFTR results in a significant stimulation of Cl Ϫ /HCO 3 Ϫ exchange, along with the induction of transcripts encoding both SLC26A3 and SLC26A6 (12) . Additionally, a correlation was recently made between the ability of CFTR mutants to regulate Cl Ϫ /HCO 3 Ϫ exchange and the associated cystic fibrosis phenotype; whereas mutants associated with pancreatic insufficiency do not promote cAMP-dependent Cl Ϫ /HCO 3 Ϫ exchange, this regulation is preserved in mutants associated with pancreatic sufficiency (7) .
Finally, the ability of Slc26a1 and Slc26a6 to mediate oxalate exchange suggests important roles for these transporters in oxalate homeostasis. Thus there is evidence for DIDS-sensitive Cl Ϫ /oxalate, OH Ϫ /oxalate, and formate/oxalate exchange in brush-border vesicles from rabbit ileum (20) , and Slc26a6 is heavily expressed in small intestine (Fig. 2 ). Slc26a1 and Slc26a6 are expressed at the basolateral (17) and apical (19) membranes, respectively, of the proximal tubule, a major site of renal oxalate secretion (47) . Hyperexcretion of oxalate is an important factor in the pathogenesis of renal stones, and increased red cell oxalate transport has been shown to segregate with oxalate excretion in certain kindreds with nephrolithiasis (3); although red cell oxalate transport has generally been attributed to AE1 (15) , this has not to our knowledge been verified by heterologous expression, and the relative role of specific anion exchangers in oxalate transport is as yet unknown. However, it is evident that dietary absorption of oxalate, potentially via SLC26A6, is an important determinant of urinary excretion (14) . Given this physiology, variation in the human SLC26A1 and/or SLC26A6 genes may be an important determinant of the risk for nephrolithiasis.
